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Objectives – Age dependency of acute ischaemic stroke aetiology and
vascular risk factors have not been adequately evaluated in stroke
patients in Norway. Aims of this study were to evaluate how stroke
subtypes and vascular risk factors vary with age in a western Norway
stroke population. Materials and methods – Patients aged 15–
100 years consecutively admitted to our neurovascular centre with
acute ischaemic stroke between 2006 and 2012 were included. The
study population was categorized as young (15–49 years), middle-aged
(50–74 years) or elderly (≥75 years). Stroke aetiology was defined by
TOAST criteria. Risk factors and history of cardiovascular disease
were recorded. Results – In total, 2484 patients with acute cerebral
infarction were included: 1418 were males (57.3%). Mean age was
70.8 years (SD  14.9), 228 patients were young, 1126 middle-aged,
and 1130 were elderly. The proportion of large-artery atherosclerosis
and of small-vessel occlusion was highest among middle-aged patients.
The proportion of cardioembolism was high at all ages, especially
among the elderly. The proportion of stroke of other determined
cause was highest among young patients. Some risk factors (diabetes
mellitus, active smoking, angina pectoris, prior stroke and peripheral
artery disease) decreased among the elderly. The proportions of
several potential causes increased with age. Conclusion – The
proportion of stroke subtypes and vascular risk factors are age dependent.
Age 50–74 years constitutes the period in life where cardiovascular risk
factors become manifest and stroke subtypes change.
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Introduction
The aetiology of stroke is influenced by sex, race
and age, as well as by cultural and geographic fac-
tors (1–6). Stroke subtypes are commonly catego-
rized as large-artery atherosclerosis (LAA),
cardioembolism (CE), small-vessel occlusion
(SVO), stroke of other determined cause (SOC)
and stroke of undetermined cause (SUC) (TOAST
criteria) (7). Pathogenesis, prognosis and treatment
vary among these subtypes, and evaluating vascular
risk factors within each subtype may improve acute
stroke treatment and secondary prevention (8).
Vascular risk factors may be classified as non-
modifiable (e.g. age, sex, race, genetics), modifi-
able and well documented (e.g. cardiovascular
disease, hypertension, diabetes mellitus, dyslipida-
emia, atrial fibrillation, smoking), or potentially
modifiable and less well documented (e.g. meta-
bolic syndrome, hyperhomocysteinemia, migraine,
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malignancy) (9, 10). Risk factor profiles change
with increasing age, as does the risk factor bur-
den (11, 12). In Norway, recent studies have
revealed a rather high-risk factor burden in the
general population (13).
Adequate data on age dependency of acute is-
chaemic stroke aetiology and the prevalence of
vascular risk factors are lacking in Norway. The
aim of this study was to evaluate how ischaemic
stroke subtypes and vascular risk factors vary
with age in a well-defined western Norway ischae-
mic stroke population.
Materials and methods
Ischaemic stroke population and aetiology
The presented study is based on data from 2484
consecutive ischaemic stroke patients aged 15–
100 years and admitted to Bergen Centre for neu-
rovascular diseases between 2006 and 2012. All
patients were prospectively registered in the Ber-
gen NORSTROKE Registry. The study popula-
tion was categorized as young (15–49 years),
middle-aged (50–74 years) or elderly (≥75 years).
The index stroke was documented by magnetic
resonance imaging (MRI) or computed tomogra-
phy (CT) confirming a lesion related to the clinical
symptoms. Routine blood samples were collected
on admission. Stroke aetiology was classified by
an experienced stroke neurologist (HN) according
to TOAST criteria (7). The proportion of different
stroke aetiologies stratified by 10 years of age
intervals is shown in Figs 1 and 2.
Vascular risk factors
Hypertension, diabetes mellitus, paroxysmal or
chronic atrial fibrillation were considered present
if diagnosed and/or treated prior to the index
stroke or during the hospital stay (fasting plasma
glucose >7.7 mmol/l; at least one ECG docu-
menting atrial fibrillation). Current smoking was
defined as smoking one or more cigarettes per
day. A history of prior stroke, transitory ischae-
mic attack (TIA), myocardial infarction, pectoral
angina or peripheral artery disease was consid-
ered present if diagnosed by a physician any time
prior to index stroke onset.
The study was approved by the local ethics
committee (REK Vest).
Statistics
STATA 13.1 (Statacorp 4905 Lakeway Drive,
College Station, TX, USA) was used for analysis.
Chi-square test, Student’s t-test, Spearman’s cor-
relation and Mann–Whitney U-test were used
when appropriate. The proportion of TOAST
subtypes was displayed by means of the Lowess
function. Figures showing the proportion of prior
cardiovascular disease (Fig. 2A) and vascular risk
factors (Fig. 2B) stratified by age decades were












































Figure 2. Proportions of prior cardiovascular disease (A) and






















Figure 1. Proportions of TOAST subtypes stratified by age
group. TOAST, Trial of Org 10172 in Acute Stroke Treat-
ment; LAA, large-artery atherosclerosis; CE, cardioembolism;
SVO, small-vessel occlusion; SOC, stroke of other determined
cause; SUC, stroke of undetermined cause.
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Results
In total, 2484 patients with acute ischaemic
stroke were included. Of these, 1418 were males
(57.3%). The mean age was 70.8 years
(SD  14.9), 228 patients were young, 1126 were
middle-aged, and 1130 were elderly. Socio-demo-
graphic characteristics, CT and MRI imaging
stratified by age group are given in Table 1.
TOAST classification stratified by age group is
shown in Fig. 1. In the total study population,
SUC was the most frequent stroke subtype
(40.2%), and CE (32.5%) dominated the deter-
mined causes (Table 2). Including only patients
that underwent full assessment with CT, MRI,
ECG, echocardiography and ultrasound of the
neck vessels (in total 32% of the patients) showed
similar curves as in Fig. 1, except that of the fre-
quency in LAA in patients >80 years old was not
so steep and the frequency of SUC decreased in
the elderly.
Figure 2 and Table 3 show the proportion of
TOAST subtypes in accordance with age. LAA
increased among middle-aged patients and
declined among the elderly, with a peak propor-
tion between 70 and 80 years. CE was a frequent
cause at all ages and showed u-shaped correlation
with decrease among the young, an increase
among the middle-aged and among elderly
patients (Table 3). The lowest proportion of CE
was between 50 and 60 years. The SVO propor-
tion peaked around 50 years and decreased there-
after both among mid-aged and elderly patients
(Table 3). The SOC proportion was highest
among the youngest patients with a peak propor-
tion between 20 and 30 years and declined in the
middle-aged. The SUC proportion increased
among the young, peaked between age 50 and 60,
and kept a steady proportion among the elderly
(Table 3). The proportion of several potential
causes in SUC increased with age, from 1% in
the young, 9% in the middle-aged to 20% in the
elderly (correlation factor 0.17, P < 0.001).
The proportions of prior cardiovascular disease
according to age are shown in Fig. 2A and
Table 3. The proportions of previous stroke,
TIA, myocardial infarction, pectoral angina and
peripheral artery disease consistently increased
with age, predominantly in the middle-aged
group (Table 3).
The proportion of vascular risk factors accord-
ing to age is shown in Fig. 2B and Table 3. The
proportion of hypertension increased consistently
with age among young and middle-aged patients.
Diabetes mellitus increased in the mid-age group
and decreased in the elderly group, peaking
between 70 and 80 years. The proportion of atrial
fibrillation increased consistently with age. The
proportion of active smoking increased with age
among the young, and decreased among the mid-
dle-aged and elderly, with a peak proportion
between 50 and 60 years.
Discussion
Our data demonstrate the correlation between
age and different aetiologies and risk factors of
ischaemic stroke for a well-defined western Nor-
way population.
Cardioembolism was the most frequent deter-
mined cause of stroke in all age groups. This con-
stellation may be explained by high rates of






n = 1130 P
n (%) n (%) n (%) P*
Socio-demographics
Females 76 (33.3) 362 (32.1) 618 (54.7) <0.001
Married 147 (64.5) 808 (71.8) 452 (40) <0.001
Employed 183 (80.3) 431 (38.3) 20 (1.7) <0.001
Imaging
Computed tomography 178 (78.07) 932 (82.77) 1056 (93.45)
Magnetic resonance
imaging
214 (93.86) 1013 (90) 815 (72.12)
*Chi-square test.
Table 2 Vascular risk factors, history of cardiovascular disease and stroke






n = 1130 P*
Vascular risk factors
Hypertension 53 (23.2) 550 (48.9) 696 (61.6) <0.001
Diabetes mellitus 16 (7.0) 161 (14.3) 173 (15.3) 0.004
Atrial fibrillation 9 (3.9) 203 (18.0) 487 (43.1) <0.001
Active smoking 81 (35.5) 406 (36.1) 117 (10.3) <0.001
History of CVD
Prior stroke 10 (4.4) 148 (13.1) 187 (16.5) <0.001
Prior TIA 9 (3.9) 75 (6.7) 105 (9.3) 0.005
Myocardial infarction 8 (3.5) 126 (11.2) 215 (19.0) <0.001
Pectoral angina 6 (2.6) 102 (9.1) 204 (18.0) <0.001
Peripheral artery disease 3 (1.3) 81 (7.2) 83 (7.4) 0.002
Stroke subtype (TOAST)
Large-artery atherosclerosis 7 (3.1) 159 (14.1) 135 (11.9) <0.001
Cardioembolism 65 (28.5) 280 (24.9) 460 (40.7) <0.001
Small-vessel occlusion 32 (14.0) 181 (16.1) 93 (8.2) <0.001
Stroke of other
determined cause
44 (19.3) 21 (1.9) 3 (0.2) <0.001
Stroke of undetermined
cause
80 (35.1) 485 (43.1) 429 (37.9) 0.02
TIA, transient ischaemic attack; CVD, cardiovascular disease; TOAST, Trial of Org




cardiac disorders with low or uncertain risk, such
as patent foramen ovale, among young patients
(5, 19, 20), whereas high-risk disorders, such as
atrial fibrillation, increased dramatically with age
(19, 20). The present data support this, as we
identified AF as an important risk factor from
the 4th decade, thereafter consistently increasing
throughout the 10th decade. However, our data
may be biased by diagnostics focusing mostly on
cardiac arrhythmias among older patients,
whereas investigation for right–left shunt with
transesophageal echocardiography and neuroso-
nographic bubble test was mostly performed
among younger patients.
Stroke of other determined cause, predomi-
nantly cervical artery dissections (19, 21), has
been described as the second most frequent cause
of stroke in the young. In our study, the propor-
tion of this subtype declined steeply during mid-
age and was non-existent among the elderly.
Other young stroke studies also support a decline
of stroke of other determined cause towards mid-
age, although their rates declined more gently
than in our study (5, 17).
Small-vessel occlusion followed an inversed
u-shaped curve with a peak in the 6th decade.
This is in line with recent studies on young and
middle-aged patients (5, 17), while others have
observed a further increase in small-vessel occlu-
sion at older ages (22). Large-artery atherosclero-
sis followed a similar time course as small-vessel
occlusions. This corresponds to that of other
stroke populations (18, 22). However, while some
studies have observed higher proportions of
large-artery atherosclerosis earlier in life (23, 24),
our population shows that large-artery athero-
sclerosis appears in the 3rd decade, but was not a
common finding before the 5th decade and there-
after increased until the 8th decade before
decreasing again.
Vascular risk factors influence both small-ves-
sel occlusion and large-artery atherosclerosis (25,
26). In our study population, all risk factors
(except smoking and diabetes mellitus) increased
consistently throughout the lifetime, but most
distinctly among middle-aged patients. Risk fac-
tors increasing with age have been reported pre-
viously (10, 11, 27). We found hypertension as
the most frequent risk factor at all ages. Hyper-
tension plays a particular role in small-vessel
occlusion (25) and is also frequently present in
large-artery atherosclerosis (18, 22). There are
some indications that large-artery atherosclerosis
and small-vessel occlusion are coexisting sub-
types of stroke (26), supporting the partly ath-
erosclerotic aetiology of small-vessel occlusion.
However, small-vessel occlusion is an imprecise
subtype, which besides occlusions due to small
artery microatheroma, lipohyalinosis and fibri-
noid necrosis, most likely also includes misinter-
preted occlusions due to embolic sources (28–
32).
Large-artery atherosclerosis is classified
according to rather rigid TOAST criteria, which
requires occlusion or ≥50% stenosis in a related
artery (7), not paying attention to atheroscle-
rotic plaque instability which may lead to arte-
rio-arterial embolism even from stenosis of low
or moderate degree (33, 34). Hence, true large-
artery atherosclerosis is in general likely to be
underestimated due to an arbitrary TOAST defi-
nition.
Table 3 Spearman’s correlation between proportions of risk factors and increasing age within three different age groups
15–49 years P 50–74 years P ≥75 years P
Risk factors
Hypertension 0.19 0.005 0.16 <0.001 0.01 0.60
Diabetes mellitus 0.11 0.09 0.07 0.01 0.06 0.03
Atrial fibrillation 0.02 0.71 0.12 <0.001 0.02 0.37
Active smoking 0.14 0.03 0.12 <0.001 0.21 <0.001
History of CVD
Prior stroke 0.05 0.41 0.07 0.01 0.007 0.79
Prior TIA 0.06 0.32 0.06 0.04 0.02 0.40
Myocardial infarction 0.05 0.38 0.07 0.01 0.03 0.31
Pectoral angina 0.06 0.31 0.11 <0.001 0.05 0.05
Peripheral artery disease 0.03 0.64 0.12 <0.001 0.03 0.29
Stroke subtype (TOAST)
Large-artery atherosclerosis 0.08 0.20 0.12 <0.001 0.13 <0.001
Cardioembolism 0.26 <0.001 0.08 0.004 0.09 <0.001
Small-vessel occlusion 0.12 0.06 0.11 <0.001 0.06 0.02
Stroke of other determined cause 0.10 0.12 0.14 <0.001 0.0007 0.10
Stroke of undetermined cause 0.21 <0.001 0.03 0.21 0.03 0.26
TIA, transient ischaemic attack; CVD, cardiovascular disease; TOAST, Trial of Org 10172 in Acute Stroke Treatment (1).
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In our total study population, stroke of unde-
termined cause was the most frequent subtype.
This illustrates a well-known limitation of the
TOAST classification, as the stroke of undeter-
mined cause category not only includes cases of
truly unknown cause, but also cases with several
potential causes (14, 15). Stroke of undetermined
cause comprised the largest subtype among young
and middle-aged patients, which is in accordance
with other studies (16, 17), whereas stroke of
undetermined cause was outnumbered by cardio-
embolism among the elderly (18). The lowest pro-
portion of stroke of undetermined cause was
found among those younger than 30 years.
The clarification of stroke aetiology has an
impact on optimal acute treatment, as well as opti-
mal secondary prevention (8, 35), and thus com-
prises a crucial part of stroke workup. Our data
show that ischaemic stroke entities change
depending on age in western Norway, and stroke
investigation needs accordingly to be focused in
different directions during different periods of life.
The proportions of some risk factors (diabetes
mellitus, active smoking, angina pectoris, prior
stroke and peripheral artery disease) decreased
among the elderly. One possible explanation is
that many patients with these risk factors died
before reaching old age.
The total number of patients in the mid-age
and elderly group was approximately the same,
but the proportions of cardiovascular disease and
vascular risk factors tended to decrease with
increasing age among the elderly as opposed to
the middle-aged. This indicates that there may be
important differences as to the underlying patho-
physiological mechanisms between these age
groups.
The strength of this study is a relatively large
study population, investigated in a single stroke
centre according to a predefined protocol. True
stroke subtype classification is negatively affected
by the TOAST classification’s own limitations,
such as oversizing the stroke of undetermined
cause subgroup and undersizing the large-artery
atherosclerosis subgroup. Another limitation is
that TOE and neurosonographic bubble test were
mainly performed among patients younger than
60 years, which may have introduced some bias
by overlooking right–left shunts in the elderly.
Also, elderly patients were examined with MRA
in only 72% of the patients and some dissections,
albeit rare, may have been missed. In stroke of
other determined cause, we may have failed to
look for some rare causes. This bias is likely
small because of the rare occurrence of diseases
such as Fabry’s disease.
Conclusions
This study demonstrates the close correlation
between age and ischaemic stroke subtypes as
well as vascular risk factors. Mid-age constitutes
the period of life where risk factors become mani-
fest and the proportions of risk factors and
stroke subtypes profoundly change among ischae-
mic stroke patients in western Norway.
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